is retatrutide approved in other countries UK 2026: Phase 3 Results Safety concerns over doctors prescribing

GLP2 once weekly for the treatment of obesity

Without cold chains , clean water , and local markets , families simply cannot change

They are being extensively used (that is, prescribed both in-label and off-label) and misused (that is, obtained without prescription online) for weight loss in the general population, under the limelight of a so-called media frenzy 12

Past performance is not a guarantee of future return, nor is it indicative of future performance

They enhance insulin when glucose is high, dampen glucagon, and slow gastric emptying, which together reduce energy intake

However, a major shift occurred in November 2025 when the Trump administration negotiated MFN pricing deals with Novo Nordisk and Eli Lilly, reducing Medicare/Medicaid prices for Ozempic, Wegovy, Zepbound, and Mounjaro to approximately $245/month , with Medicare beneficiary co-pays of $50/month ( [17] ) ( [22] )